Precision medicine research requires high-density genotyping arrays that deliver reproducible results and no loss of SNP markers from lot to lot. The Axiom™ Precision Medicine Research Array offers the highest genomic coverage selected for global screening for the five ancestral populations covering more than 25 ethnic and admixed worldwide populations at various 1000 Genomes Phase 3 minor allele frequency ranges. Prioritizing 100,000 clinically relevant markers selected from public databases, including ClinVar, CPIC, PharmaGKB, and PharmaADME, this array is ideal for multi-year precision medicine cohort studies and global screening initiatives.

The Axiom Precision Medicine Research Array is a broad and powerful genotyping resource for researchers driving deeper scientific insights into a variety of important health questions related to common and rare inherited diseases, genetic risk profiling, immune response, pharmacogenomics research, and many other areas associated with precision medicine.

The Axiom Precision Medicine Research Array is suitable for precision medicine research for dense genotyping. It may be customized with de novo markers or markers selected from the Axiom™ Genomic Database of genotype-tested markers. Highlights of the Precision Medicine Research Array include:

  • Evidence based precision medicine content—GWAS to clinical research
  • Broad, entry-level offering for multidisciplinary research
  • Customization up to  50,000 novel markers
  • No minimums with flexible delivery terms